Company page

Newamsterdam Pharma Company N.v.

Newamsterdam Pharma Company N.V. is a public company traded under the ticker NAMS in the American market. With a market capitalization of approximately $3.55 billion, the company focuses on developing innovative pharmaceutical solutions. As a publicly listed entity, Newamsterdam Pharma is committed to advancing healthcare through its research and development initiatives.